Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Visceral leishmaniasis clinical management in endemic districts of India, Nepal, and Bangladesh
Institute of Medicine, Tribhuvan University, Kathmandu 44168, Nepal.
Umeå University, Faculty of Medicine, Department of Epidemiology and Global Health. KEM Hospital Research Center, Pune, Maharashtra 411011, India.
Rajendra Memorial Research Institute of Medical Sciences, Patna, Bihar 800007, India.
Rajendra Memorial Research Institute of Medical Sciences, Patna, Bihar 800007, India.
Show others and affiliations
2012 (English)In: Journal of Tropical Medicine, ISSN 1687-9686, E-ISSN 1687-9694, Vol. 2012, article id 126093Article in journal (Refereed) Published
Abstract [en]

Background: National VL Elimination Programs in India, Nepal and Bangladesh face challenges as home-based Miltefosine treatment is introduced. Objectives. To study constraints of VL management in endemic districts within context of national elimination programs before and after intervention.

Methods: Ninety-two and 41 newly diagnosed VL patients were interviewed for clinical and provider experience in 2009 before and in 2010 after intervention (district training and improved supply of diagnostics and drugs). Providers were assessed for adherence to treatment guidelines. Facilities and doctor-patient consultations were observed to assess quality of care.

Results: Miltefosine use increased from 33% to 59% except in Nepal where amphotericin was better available. Incorrect dosage and treatment interruptions were rare. Advice on potential side effects was uncommon but improved significantly in 2010. Physicians did not rule out pregnancy prior to starting Miltefosine. Fever measurement or spleen palpation was infrequently done in Bangladesh but improved after intervention (from 23% to 47%). Physician awareness of renal or liver toxicity as Miltefosine side effects was lower in Bangladesh. Bio-chemical monitoring was uncommon. Patient satisfaction with services remained low for ease of access or time provider spent with patient. Health facilities were better stocked with rK39 kits and Miltefosine in 2010. 

Place, publisher, year, edition, pages
Hindawi Publishing Corporation, 2012. Vol. 2012, article id 126093
National Category
Public Health, Global Health, Social Medicine and Epidemiology
Identifiers
URN: urn:nbn:se:umu:diva-200612DOI: 10.1155/2012/126093Scopus ID: 2-s2.0-84862291360OAI: oai:DiVA.org:umu-200612DiVA, id: diva2:1708100
Available from: 2022-11-02 Created: 2022-11-02 Last updated: 2022-11-02Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textScopus

Authority records

Hirve, Siddhivinayak

Search in DiVA

By author/editor
Hirve, Siddhivinayak
By organisation
Department of Epidemiology and Global Health
In the same journal
Journal of Tropical Medicine
Public Health, Global Health, Social Medicine and Epidemiology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 12 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf